Pain Control in OUD | Is Syncope Worth An Admission?
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Pain Control in OUD | Is Syncope Worth An Admission?
-
ナレーター：
-
著者：
The JournalFeed podcast
These are summaries from just 2 of the 5 articles we cover every week! For access to more, please visit JournalFeed.org for details about becoming a member.
Monday’s Spoon Feed:
For hospitalized patients with opioid use disorder (OUD) experiencing acute pain, higher doses of opioids are often needed, in addition to non-opioid analgesics. Medication for OUD (MOUD) such as buprenorphine or methadone should be offered or continued if previously taking, assistance from addiction medicine services and/or acute pain services should be sought, timely hospital follow-up should be arranged, and naloxone should be prescribed at discharge.
Wednesday’s Spoon Feed:
This secondary analysis of adults ≥ 40 years old with syncope or pre-syncope without a serious diagnosis made in the ED found 5.9% of patients had a serious adverse outcome (SAO) within 30 days.